15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Brookfield Corp, 7 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $52.00 to $78.00, a moderate spread. The average target of $60.57 sits 43% above the current $42.38. The rating mix has held broadly steady over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Moderate Buy
Strong Buy00%
Buy7100%
Hold00%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to Brookfield Corp.
As of Jul, 7 of 7 firms rate BN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BN EPS & revenue forecast
EPS · NEXT QUARTER
—
Range — – — · 1 analysts
Next period, 1 analysts expect Brookfield Corp to earn — a share (range — – —), versus — a year earlier.
REVENUE · NEXT QUARTER
$1.9B
Range $1.9B – $1.9B · 1 analysts
Revenue is expected to reach $1.9B (range $1.9B – $1.9B). Full-year consensus is $7.6B, rising to $9.2B next year.
Top analysts covering Brookfield Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BN.
#1
Michael Cyprys
Morgan Stanley · Rank #253
Buy
$59.00+39.2% to target
Overall win rate
39%
+ Follow
#2
MS
Mario Saric
Scotiabank
Buy
$53.00+25.1% to target
Coverage
—
+ Follow
#3
BD
Bart Dziarski
RBC Capital
Buy
$61.00+43.9% to target
Coverage
—
+ Follow
#4
DW
Dean Wilkinson
CIBC
Buy
$52.00+22.7% to target
Coverage
—
+ Follow
#5
CR
Cherilyn Radbourne
TD Securities
Buy
$59.00+39.2% to target
Coverage
—
+ Follow
BN stock forecast FAQ
What is BN's average 12-month price target?+
The 7 analysts with a live target average $60.57 for Brookfield Corp over the next 12 months, ranging from a $78.00 high to a $52.00 low.
Is BN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 7 analyst ratings, 7 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BN?+
The Street-high target is $78.00 (Goldman Sachs), and the Street-low is $52.00 (CIBC). The average of all 7 active targets is $60.57.
How many Wall Street analysts cover BN?+
7 analysts have an active rating on Brookfield Corp, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering BN?+
Among analysts who currently cover BN, Michael Cyprys of Morgan Stanley has the strongest overall Quantellect track record (Rank #253). Their current call is Buy with a $59.00 target.
What is Brookfield Corp's projected EPS for next quarter?+
The consensus estimate is — per share (range — – —) across 1 analysts. Full-year EPS is projected at —, rising to — the following year.
How much revenue is Brookfield Corp expected to report next quarter?+
Consensus revenue is $1.9B (range $1.9B – $1.9B). Full-year revenue is projected at $7.6B, growing to $9.2B next year.
Have analysts been upgrading or downgrading BN lately?+
As of Jul, 7 of 7 firms rate BN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
